Agilent to present precision oncology and digital pathology advances at USCAP 2026

Reuters
03/19
Agilent to present precision oncology and digital pathology advances at USCAP 2026
  • Agilent plans to attend the USCAP Annual Meeting on March 21-26, 2026, in San Antonio, Texas.
  • A Digital Pathology Symposium titled “Future Ready Total Pathology Workflows: Integrating Advanced Staining and Digital Solutions in Today's Practice” is scheduled for March 23, 2026, 12:00-1:00 p.m., in Seminar Room 7.
  • A session titled “Gastric Cancer and PD-L1 Expression: Morphology, Biomarker Landscape, and Case Analysis” is scheduled for March 24, 2026, 12:00-1:00 p.m., in Seminar Room 2.
  • A session titled “PD-L1 in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC): Scoring for a Newly Established Indication” is scheduled for March 25, 2026, 12:00-1:00 p.m., in Seminar Room 2.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agilent Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260319962666) on March 19, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10